"Das Krankenhaus der Barmherzigen Brüder wurde 1614 gegründet und liegt zentral im 2. Wiener Gemeindebezirk. Wir sind das älteste Ordensspital in Wien. Bei uns erfahren PatientInnen neben bester ärztlicher Versorgung und optimaler Pflege auch menschliche Zuwendung und christliche Nächstenliebe. Heute zählen wir nicht nur zu den größten Spitälern der Bundeshauptstadt sondern auch zu den modernsten, stets am neuesten Stand der medizintechnischen Möglichkeiten. Mehr als 400 Betten, zehn Fachabteilungen, zwei Institute sowie eine öffentlich angeschlossene Apotheke machen uns zu einer wertvollen Stütze im lokalen Gesundheitswesen und zu einem wichtigen Gesundheitszentrum für die Wiener Bevölkerung."

During the past decade, Krankenhaus der Barmherzigen Brüder conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 4 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 3 clinical trials were completed. i.e. 37.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Krankenhaus der Barmherzigen Brüder" #1 sponsor was "Janssen Research & Development, LLC" with 4 trials, followed by "Bayer" with 3 trials sponsored, "Austrian Breast & Colorectal Cancer Study Group" with 2 trials sponsored, "Advanced Medical Diagnostics s.a." with 1 trials sponsored and "Barmherzige Brüder Vienna" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Krankenhaus der Barmherzigen Brüder" #1 collaborator was "AF Schimetta GMbH" with 1 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "European Commission" with 1 trials as a collaborator, "Everest Medicines" with 1 trials as a collaborator and "Hoffmann-La Roche" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Krankenhaus der Barmherzigen Brüder" are "Crohn Disease" (2 trials), "Acute Non-cardioembolic Ischemic Stroke" (1 trials), "Anastomotic Leak Rectum" (1 trials), "BRAF V600E-mutant Metastatic Colorectal Cancer" (1 trials) and "Breast Cancer" (1 trials). Many other conditions were trialed in "Krankenhaus der Barmherzigen Brüder" in a lesser frequency.

Most popular intervention types in "Krankenhaus der Barmherzigen Brüder" are "Drug" (12 trials), "Device" (4 trials), "Biological" (3 trials), "Other" (3 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Docetaxel" (2 trials), "Placebo" (2 trials), "Rogaratinib (BAY1163877)" (2 trials), "Vinflunine" (2 trials) and "Atezolizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Krankenhaus der Barmherzigen Brüder" are 14 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Krankenhaus der Barmherzigen Brüder". undefined are not yet recruiting, 6 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Krankenhaus der Barmherzigen Brüder, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Krankenhaus der Barmherzigen Brüder, 1 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".